HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

• 2022-10-03 Meeting Notes - accepted by general consent

Project Review

Project Proposals

• PSS-2123 - Getting issue details... STATUS - Imaging ServiceRequest - no requirement for Pharmacy to be involved

Project Scope Statements

• PSS-2113 - Getting issue details... STATUS - ValueBased Performance Reporting Implementation Guide - sponsored by CQI
  • no requirement for Pharmacy to be involved

External Meeting Review

Catalog Updates (John Hatem)

• 17 Oct 2022 - no updates

Workflow Update (John Hatem) 

• 17 Oct 2022 - no meeeting

Healthcare Product Update (John Hatem)

• 17 Oct 2022 - discussing trackers - 1 tracker to be reviewed

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

• 17 Oct 2022 - unaware of meetings
  • John and Scott have been reviewing documents

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/

• 17 Oct 2022 - WG meeting Nov 2-4, 2022
  • Shelly - NCPDP Task Group looking at writing a paper on Med List and Med Reconciliation
    • will be creating a FHIR profile for Standardized Medication Profile (SMP) - looking for funding

Projects

Pharmacist Consult Note (Scott)

• 03 Oct 2022 - Ballot Reconciliation Status.  
  • Scott has triaged the comments.  Several typo/editorial; others will require review and potential changes. 
  • 3 comments against Pharmacy Templates are actually for Consult Note.  will be transferred.
• 17 Oct 2022 
  • 3 comments to be cloned across to the Consult Note
  • Scott has reviewed the comments 
  • Have been reviewing at NCPDP TG
  • Voting must take place at HL7
  • OTHER-2367 - re-opened as vote must be done in Pharmacy WG
    • Medication is listed as "should", but needs to be "shall"
    • Pharmacists may get consult notes that don't include medications - so will not change
    • Motion:  Scott Robertson - Shelly Spiro - 8-0-1 - Carried
  • OTHER-2357 - which CDA Structure should be used to include pharmacist recommendations
    • "Assessment and plan" will include pharmacists impressions and recommendations - in both of CDA and FHIR - required
    • Plan of treatment section - details pharmacist recommendations
    • Question answered - See Section 5.2.2
    • No vote required
  • OTHER-2356 - Medication Section - suggest change to Required
    • not persuasive with Mod - include an example of why the medication is not present in the IG to clarify
    • Motion - Scott Robertson - John Hatem - 9-0-0 Carried
  • OTHER-2355 - US Realm Header - FHIR Composition
    • agree to add
    • Motion - Scott Robertson - Stephen Chu 9-0-0 Carried 
  • Scott will group issues and put out a block vote for some

Pharmacy Templates

• 03 Oct 2022  Ballot Reconciliation Status.  Giorgio will present reconciliation work in a future meeting
• 17 Oct 2022 - no discussion

Specialty Medication Enrolment IG

• 03 Oct 2022 - Ballot Reconciliation Status. 
  • Frank McKinney will present reconciliation work in a future meeting
• 17 Oct 2022 no discussion

Withdrawal of HL7 Version 3 Standard: Pharmacy; Medication Statement, Release 1

• 03 Oct 2022 
  • one vote against appears to confuse the V3 item with FHIR MedicationStatement.  Balloter to be contacted
• 17 Oct 2022  - have reached out to submitter of 1 negative comment - no response
  • MOTION to find negative comment not persuasive as this is V3 Medication Statement - Melva Peters - Scott Robertson - 9-0-0 Carried
  • Jean Duteau to create reconciliation spreadsheet and post and let Lynn know to withdraw

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

• FHIR-37980 - new text re: boundaries and scope for SupplyDelivery
  • New wording proposed from Pharmacy and added to Jira Issue

Any Other Business

• Zulip question:  Mapping additionalInstruction to C-CDA - no discussion

Next meeting:

• 24 Oct 2022